Group PG150 [Figure 4c] shows slight improvement on hepatocyte degeneration (Score 4), while more improvement was noticed (Score 2) in group PG300 [Figure 4d]
40 Gonzalez FlechaB
The central clinical idea: when mitochondrial ATP production falls and oxidative stress rises, the brain may lose the energy and antioxidant reserve needed to regulate neurotransmission, maintain cell membranes, recycle methionine, produce SAM, clear adenosine and homocysteine, build glutathione and tolerate medications or supplements
Potency is verified every 36 months to confirm each batch remains within 10% of the intended concentration
Caveat: "3%" refers to a copper amino isolate complex, not necessarily 3% pure GHK-Cu by mass
It has also been shown to work within brain cells by assisting in the maintenance of the cellular mitochondria, the powerhouse portion of the cell where nutrients are converted to energy